Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Flovent

Fluticasone Propionate

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Flovent:

 BioPortfolio Logo
Generic Erosion, Increased Competition and Cost Consciousness Will Reduce Overall Asthma Drug Market by $1.8 Billion from 2008 to 2018 8th June, 2009 Decision Resources
Principal Factor Driving the Market Decline Will be Singulair's Loss of Brand Exclusivity, According to a New Report from Decision Resources WALTHAM, Mass., June 8 /PRNewswire/ -- Decision
MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Medical Affairs 23rd July, 2008 MAP Pharmaceuticals, Inc.
MOUNTAIN VIEW, Calif., July 23 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced the appointment of Donald J. Kellerman, Pharm.D. to the position of Senior Vice

This page has been viewed 27 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Flovent across BioPortfolio, or for Flovent Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.